TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
NAGE

Niagen Bioscience, Inc.

Healthcare · Biotechnology · —

3.00$ -0.3% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Niagen Bioscience, Inc. (NAGE): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/04/2026
Earnings surprise by quarter (%)
Q3 23 · 66.7 % 23 Q4 23 · 106.7 % 23 Q1 24 · 0.0 % 24 Q2 24 · 257.0 % 24 Q3 24 · 100.0 % 24 Q4 24 · 350.0 % 24 Q1 25 · 150.0 % 25 Q2 25 · 300.0 % 25 Q3 25 · 150.0 % 25 Q4 25 · 25.5 % 25 Q1 26 · -66.7 % 26 Q2 26 · 0.0 % 26

EPS estimate beaten

Full history 15 of 40 quarters (38%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

  • 05/06/2026 Earnings Call Q1 2026 Open →
  • 03/04/2026 Earnings Call Q4 2025 Open →
  • 11/04/2025 Earnings Call Q3 2025 Open →

News on This Stock

  • 08/04/2026 Niagen Bioscience, Inc. (NAGE): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?